Detalhe da pesquisa
1.
Outpatient clinical pharmacy practice in the face of COVID-19 at a cancer center in New York City.
J Oncol Pharm Pract
; 27(2): 389-394, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33459159
2.
Evaluation of toxicity of carmustine with or without bevacizumab in patients with recurrent or progressive high grade gliomas.
J Neurooncol
; 145(1): 57-63, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31432377
3.
Incidence of skeletal related events in patients with bone metastasis receiving denosumab every four weeks compared to intervals greater than every four weeks.
J Oncol Pharm Pract
; 25(3): 529-534, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29207934
4.
Incidence of hypocalcemia in patients receiving denosumab for prevention of skeletal-related events in bone metastasis.
J Oncol Pharm Pract
; 23(3): 179-184, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26830549
5.
Use of naloxone for reversal of life-threatening opioid toxicity in cancer-related pain.
J Oncol Pharm Pract
; 22(1): 114-20, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25227231
6.
A systematic approach towards missing lab data in electronic health records: A case study in non-small cell lung cancer and multiple myeloma.
CPT Pharmacometrics Syst Pharmacol
; 12(9): 1201-1212, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37322818
7.
Is more better? Increased doses of high dose methotrexate and addition of rituximab is associated with improved outcomes in a large primary CNS lymphoma cohort.
Ann Lymphoma
; 72023 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37067886
8.
Rituximab, Methotrexate, Carmustine, Etoposide, and Prednisone (RMBVP) for the treatment of relapsed/refractory primary central nervous system lymphoma: a retrospective single-center study.
Leuk Lymphoma
; 63(3): 627-632, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34758711
9.
Immunotherapy in Gliomas.
Semin Oncol Nurs
; 34(5): 501-512, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30396808
10.
Retrospective review of safety and efficacy of programmed cell death-1 inhibitors in refractory high grade gliomas.
J Immunother Cancer
; 5(1): 99, 2017 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29254497
11.
Nonrandomized Comparison of Adverse Events Following Facility- and Home-Infused Biologics Using Real-World Data.
JAMA Netw Open
; 4(6): e2111156, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34081142